Armata Pharmaceuticals, Inc. (ARMP)
5.77
+0.25
(+4.53%)
USD |
NYAM |
Sep 04, 13:15
Armata Pharmaceuticals Market Cap : 214.33M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 205.04M |
| September 02, 2026 | 205.42M |
| September 01, 2026 | 196.13M |
| August 31, 2026 | 204.67M |
| August 28, 2026 | 199.47M |
| August 27, 2026 | 201.70M |
| August 26, 2026 | 202.44M |
| August 25, 2026 | 206.53M |
| August 24, 2026 | 192.04M |
| August 21, 2026 | 189.44M |
| August 20, 2026 | 164.18M |
| August 19, 2026 | 188.33M |
| August 18, 2026 | 169.38M |
| August 17, 2026 | 166.41M |
| August 14, 2026 | 169.38M |
| August 13, 2026 | 179.04M |
| August 12, 2026 | 160.10M |
| August 11, 2026 | 157.87M |
| August 10, 2026 | 170.87M |
| August 07, 2026 | 171.59M |
| August 06, 2026 | 171.23M |
| August 05, 2026 | 171.23M |
| August 04, 2026 | 170.50M |
| August 03, 2026 | 183.98M |
| July 31, 2026 | 165.40M |
| Date | Value |
|---|---|
| July 30, 2026 | 174.14M |
| July 29, 2026 | 166.49M |
| July 28, 2026 | 172.32M |
| July 27, 2026 | 187.62M |
| July 24, 2026 | 169.77M |
| July 23, 2026 | 190.17M |
| July 22, 2026 | 190.90M |
| July 21, 2026 | 187.99M |
| July 20, 2026 | 184.34M |
| July 17, 2026 | 164.31M |
| July 16, 2026 | 136.98M |
| July 15, 2026 | 145.36M |
| July 14, 2026 | 142.81M |
| July 13, 2026 | 144.63M |
| July 10, 2026 | 155.20M |
| July 09, 2026 | 175.96M |
| July 08, 2026 | 185.80M |
| July 07, 2026 | 193.45M |
| July 06, 2026 | 198.19M |
| July 02, 2026 | 214.58M |
| July 01, 2026 | 214.22M |
| June 30, 2026 | 236.08M |
| June 29, 2026 | 235.35M |
| June 26, 2026 | 269.59M |
| June 25, 2026 | 236.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 353.71M |
| Amgen, Inc. | 236.19B |
| Anika Therapeutics, Inc. | 280.51M |
| BioCryst Pharmaceuticals, Inc. | 2.536B |
| Imunon, Inc. | 7.325M |
Market Cap Related Metrics
| PS Ratio | 44.54 |
| PEG Ratio | -0.0008 |
| Price | 5.77 |
| Earnings Yield | -131.5% |
| PEGY Ratio | -0.0008 |